ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
4,05
-0,21
(-4,93%)
Fermé 09 Juin 10:00PM
3,8911
-0,1589
(-3,92%)
Après les heures de négociation: 1:55AM

Quantum Biopharma Ltd (QNTM) Action

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
3,8911
( -8,66% )
Prix Achat
3,82
Prix Vente
4,32
Volume échangé
265 328
3,90 Fourchette du Jour 4,58
2,07 Plage de 52 semaines 38,25
Cap du marché
Clôture Veille
4,26
Ouverture
4,30
Dernière Transaction
150
@
3.8911
(formt)
Dernière heure de transaction
Volume financier
US$ 1 113 459
VWAP
4,1965
Volume moyen (3 m)
US$ 22 999
Actions en circulation
6 398 647
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-0,52
Bénéfice par action (BPA)
-8,22
Chiffre d'affairess (LTM)
-
Bénéfice net (LTM)
-31,16M

À propos de Quantum Biopharma Ltd

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegener... Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company’s lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. It also develops FSD-PEA, which is in preparation for Phase 2 trial for the treatment of inflammatory diseases, such as mast cell activation syndrome; Lucid-PSYCH to treat major depressive disorder; and unbuzzd, a dietary supplement for the treatment of alcohol misuse. In addition, the company maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd. was founded in 1998 and is based in Toronto, Canada. Show more

Secteur
Healthcare
Industrie
Pharmaceuticals
Siège social
Toronto, Canada
Fondé
1998
Quantum Biopharma Ltd est coté dans le secteur Healthcare de la NASDAQ avec le ticker QNTM. Le dernier cours de clôture d'Quantum Biopharma était de US$4,26. Au cours de la dernière année, les actions de Quantum Biopharma ont été négociées dans une fourchette de prix de US$ 2,07 à US$ 38,25.

Quantum Biopharma compte actuellement 6 398 647 actions en circulation. La capitalisation boursière d'Quantum Biopharma est de US$24,90 million. Quantum Biopharma a un ratio cours/bénéfice (ratio PE) de -0.52.

QNTM Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-2.8089-41.9238805976.76.713.89115251084.85216435CS
4-0.8989-18.76617954074.7910.80993.89115239496.61374286CS
121.421157.53441295552.4710.80992.185213945.03437356CS
26-6.2089-61.474257425710.111.492.073124644.88943669CS
52-11.5589-74.814886731415.4538.252.0724701410.2822595CS
156-1.0089-20.58979591844.938.252.075672848.95024621CS
260-1.0089-20.58979591844.938.252.075672848.95024621CS

QNTM - Frequently Asked Questions (FAQ)

What is the current Quantum Biopharma Ltd share price?
The current share price of Quantum Biopharma Ltd is US$ 3,8911
How many Quantum Biopharma Ltd shares are in issue?
Quantum Biopharma Ltd has 6 398 647 shares in issue
What is the market cap of Quantum Biopharma Ltd?
The market capitalisation of Quantum Biopharma Ltd is USD 24,9M
What is the 1 year trading range for Quantum Biopharma Ltd share price?
Quantum Biopharma Ltd has traded in the range of US$ 2,07 to US$ 38,25 during the past year
What is the PE ratio of Quantum Biopharma Ltd?
The price to earnings ratio of Quantum Biopharma Ltd is -0,52
What is the registered address of Quantum Biopharma Ltd?
The registered address for Quantum Biopharma Ltd is 1 Adelaide Street East, Toronto, Ontario, M5C 2V9
What is the Quantum Biopharma Ltd website address?
The website address for Quantum Biopharma Ltd is www.quantumbiopharma.com
Which industry sector does Quantum Biopharma Ltd operate in?
Quantum Biopharma Ltd operates in the Pharmaceuticals sector

QNTM Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock